Overall, our analysis demonstrates that such NRG1-rearranged gynecologic neoplasms are rare, with only 26 total examples identified within the total gynecologic tract cancer specimens that underwent whole transcriptome sequencing—an incidence of 0.18% among carcinomas of the ovary, fallopian tube, and peritoneum. This evidence concerns the gene NRG1 and female reproductive system neoplasm.